These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 25598674)
21. A case of intrahepatic cholangiocarcinoma involving the proper hepatic artery. Nara S; Sakamoto Y Jpn J Clin Oncol; 2006 Sep; 36(9):608. PubMed ID: 17028123 [No Abstract] [Full Text] [Related]
22. Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis. Kim AY; Jeong WK Clin Mol Hepatol; 2016 Mar; 22(1):192-7. PubMed ID: 27044773 [No Abstract] [Full Text] [Related]
23. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484 [TBL] [Abstract][Full Text] [Related]
24. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051 [TBL] [Abstract][Full Text] [Related]
25. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Roskams T Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type. Chen J; He J; Deng M; Wu HY; Shi J; Mao L; Sun Q; Tang M; Fan XS; Qiu YD; Huang Q Hum Pathol; 2017 Jun; 64():118-127. PubMed ID: 28431889 [TBL] [Abstract][Full Text] [Related]
27. Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Colli A; Cocciolo M; Mumoli N; Cesarini L; Prisco A; Gaffuri I; Martinez E Eur J Ultrasound; 1998 Apr; 7(2):93-9. PubMed ID: 9614277 [TBL] [Abstract][Full Text] [Related]
28. [Hepatocellular carcinoma and cholangiocarcinoma]. Rauchfuss F; Scheuerlein H; Götz M; Dittmar Y; Voigt R; Heise M; Settmacher U Chirurg; 2010 Oct; 81(10):941-52; quiz 953. PubMed ID: 20827454 [TBL] [Abstract][Full Text] [Related]
29. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800 [TBL] [Abstract][Full Text] [Related]
30. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309 [TBL] [Abstract][Full Text] [Related]
31. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. Tajima T; Honda H; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Taguchi K; Shimada M; Masuda K J Comput Assist Tomogr; 1999; 23(5):690-5. PubMed ID: 10524847 [TBL] [Abstract][Full Text] [Related]
32. Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma. Gigante E; Ronot M; Bertin C; Ciolina M; Bouattour M; Dondero F; Cauchy F; Soubrane O; Vilgrain V; Paradis V Liver Int; 2019 Dec; 39(12):2386-2396. PubMed ID: 31544304 [TBL] [Abstract][Full Text] [Related]
35. Uncommon liver tumors: Case report and literature review. Wu CH; Chiu NC; Yeh YC; Kuo Y; Yu SS; Weng CY; Liu CA; Chou YH; Chiou YY Medicine (Baltimore); 2016 Sep; 95(39):e4952. PubMed ID: 27684838 [TBL] [Abstract][Full Text] [Related]
36. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan. Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199 [No Abstract] [Full Text] [Related]
37. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma. Anysz-Grodzicka A; Podgorska J; Cieszanowski A Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878 [TBL] [Abstract][Full Text] [Related]
38. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed. Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157 [TBL] [Abstract][Full Text] [Related]
39. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones". Hunt JP; Varnholt H Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649 [No Abstract] [Full Text] [Related]
40. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]